Overview Request Sample Pages Request Customization Download PDF
You are viewing: Germany Blood Collection Devices Market analysis

The Germany Blood Collection Devices Market was valued at $728.1 Million in 2025 and projected to reach to $1086.3 Million by 2030, representing a compound annual growth rate of 8.3%. Germany's blood collection devices market is poised for sustained expansion driven by its aging population, advanced healthcare infrastructure, and commitment to occupational safety standards.

Germany Blood Collection Devices Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Germany Blood Collection Devices Market Trends and Insights

  • This expansion reflects Germany's advanced healthcare infrastructure, stringent regulatory standards, and increasing demand for safe phlebotomy solutions across hospitals, diagnostic laboratories, and blood banks.
  • Germany's aging population and rising prevalence of chronic diseases are driving higher volumes of blood testing and transfusion procedures, necessitating modern collection technologies. The German market benefits from strong adoption of safety-engineered devices and automation in blood collection workflows.
  • Germany's commitment to occupational safety and infection control standards accelerates the transition from conventional to advanced collection systems.
  • Key drivers include investments in healthcare digitalization, growing awareness of bloodborne pathogen risks, and the presence of leading medical device manufacturers headquartered in Germany.
  • The 8.3% compound annual growth rate underscores sustained demand for innovative collection devices through 2030..

Key Market Statistics

  • CAGR (2025-2030) 8.3% CAGR
  • Market Size, 2025 ~USD 728.1 Million
  • Forecast, 2030 ~USD 1086.3 Million
  • Country Germany

Germany Blood Collection Devices Market Overview

Market Valuation Growth :

Germany's blood collection devices market is valued at $728.1 million in 2025, with a projected CAGR of 8.3% through 2030, reaching $1,086.3 million. This growth outpaces the global average of 7.4%, reflecting strong domestic demand.

Advanced Healthcare Infrastructure :

Germany's world-class healthcare system, characterized by high diagnostic standards and widespread adoption of safety-engineered devices, drives consistent demand for innovative blood collection solutions across all clinical settings.

Aging Population Demographics :

Germany's aging demographic profile increases the prevalence of chronic diseases requiring frequent blood testing and monitoring, creating sustained demand for reliable phlebotomy devices in hospitals, clinics, and diagnostic laboratories.

Regulatory Excellence & Safety Standards :

Stringent German and EU regulatory requirements mandate compliance with highest safety standards, positioning Germany as a premium market where manufacturers prioritize quality, sterility, and needle-stick injury prevention technologies.

Germany Blood Collection Devices Market Dynamics

  • The country's robust diagnostic sector, encompassing hospitals, specialized laboratories, and blood banks, continues to invest in modern phlebotomy equipment.
  • Regulatory compliance with EU directives and German quality standards ensures consistent adoption of safety-engineered devices.
  • The market will benefit from increasing awareness of bloodborne pathogen prevention and rising healthcare expenditures.
  • Innovation in butterfly needles, vacuum tubes, and automated collection systems will further accelerate growth through 2030..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • Germany's blood collection devices market will grow from $728.1M (2025) to $1,086.3M (2030) at an 8.3% CAGR.
      • Germany's stringent occupational safety regulations and infection control standards drive adoption of safety-engineered collection devices.
      • Germany's aging demographic and chronic disease prevalence increase demand for blood testing and transfusion services.
      • Germany's healthcare digitalization and automation investments enhance efficiency in blood collection workflows.

      Blood Collection Devices Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment PLASMA/WHOLE BLOOD TUBES (Type)
      Forecast Period 2025–2030
      Growth Rate CAGR of 7.4% from 2025 to 2030
      Largest Segment MANUAL BLOOD COLLECTION (Method)
      Market Size Base Year (Billions) ~USD 9.11 (2025)
      Revenue Forecast (Billions) ~USD 13.02 (2030)
      Segments Covered Product, Type, System Type, Method, Application, End User

      Germany Blood Collection Devices Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product

      • Blood Bags
      • Blood Collection Systems/ Monitors
      • Blood Collection Tubes
      • Lancets
      • Needle & Syringes

      By Type

      • Coagulation Tubes
      • Edta Tubes
      • Esr Tubes
      • Glucose Tubes
      • Heparin Tubes
      • Plasma/Whole Blood Tubes
      • Serum Tubes

      By System Type

      • Non-Vacuum Type
      • Vacuum Type

      By Method

      • Automated Blood Collection
      • Manual Blood Collection

      By Application

      • Diagnostic Applications
      • Therapeutic Applications

      By End User

      • Blood Banks
      • Diagnostic & Pathology Labs
      • Hospitals, Ambulatory Surgical Centers, And Nursing Homes
      • Other End Users

      GERMANY: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030

      Segment20232024202520262027202820292030CAGR (%)
      BLOOD BANKS106.2112.9119125.9133.9143153.2164.76.7
      DIAGNOSTIC & PATHOLOGY LABS143.1154.4165177191206.8224.72458.2
      HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES341.9371.9400.9433.5471.4514.3563618.49.1
      OTHER END USERS38.941.243.245.548.151.154.558.36.2
      TOTAL630.2680.4728.1782844.4915.1995.31086.38.3

      Target Audience

      • Medical Device Manufacturers : Manufacturers need Germany-specific market data to develop localized product strategies, understand regulatory pathways, and identify distribution opportunities in Europe's largest healthcare market.
      • Healthcare Facility Administrators : Hospital and laboratory managers require market insights to benchmark procurement decisions, evaluate supplier options, and justify investments in safety-engineered blood collection devices.
      • Diagnostic Laboratory Operators : Laboratory directors need market forecasts and demographic trends to plan equipment upgrades, optimize phlebotomy workflows, and ensure compliance with German safety standards.
      • Investment & Private Equity Firms : Investors evaluating healthcare sector opportunities in Germany need detailed market sizing, growth projections, and competitive analysis to assess acquisition targets and portfolio companies.
      • Healthcare Consultants & Analysts : Consultants advising healthcare organizations require Germany-specific market data, regulatory insights, and demographic analysis to support strategic recommendations and business case development.

      Key Companies in the Germany Blood Collection Devices Market

      CompanyHQOwnershipStrongest segments
      ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyTurnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions,
      ABBOTT LABORATORIESUnited StatesPublic CompanyMedical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula),
      NOLATOSwedenPublic CompanyMedical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC),
      QIAGEN NVNetherlandsPublic CompanySample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays,
      DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables),
      GRIFOLS, S.A.SpainPublic CompanyBiopharma (plasma-derived medicines),Diagnostic,Bio Supplies,
      NIPRO CORPORATIONJapanPublic CompanyRenal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components),
      HAEMONETICS CORPORATIONUnited StatesPublic CompanyPlasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+),
      ICU MEDICAL, INC.United StatesPublic CompanyInfusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware,
      CARDINAL HEALTHUnited StatesPublic CompanyBranded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands),
      RETRACTABLE TECHNOLOGIES, INC.United StatesPublic CompanyVanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps,
      AB MEDICAL CO., LTD.IrelandPublic CompanyCardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio,

      ATS AUTOMATION TOOLING SYSTEMS INC

      ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.

      ABBOTT LABORATORIES

      Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.

      NOLATO

      Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.

      QIAGEN NV

      QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.

      DANAHER CORPORATION

      Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.

      GRIFOLS, S.A.

      Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.

      NIPRO CORPORATION

      Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.

      HAEMONETICS CORPORATION

      Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.

      ICU MEDICAL, INC.

      ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.

      CARDINAL HEALTH

      Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.

      RETRACTABLE TECHNOLOGIES, INC.

      Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.

      AB MEDICAL CO., LTD.

      AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.

      Reasons to Buy this Report

      • Market-Specific Growth Projections : Access precise forecasts for Germany's blood collection market through 2030, with detailed CAGR analysis (8.3%) that exceeds global averages, enabling accurate business planning and investment decisions.
      • Regulatory & Compliance Insights : Understand Germany's stringent EU and national regulatory requirements for blood collection devices, ensuring your products meet the highest safety and quality standards demanded by German healthcare providers.
      • Demographic-Driven Demand Analysis : Leverage insights into Germany's aging population trends and their impact on diagnostic testing volumes, helping you identify growth opportunities in hospitals, laboratories, and blood banking facilities.
      • Competitive Landscape Intelligence : Gain strategic understanding of the German market structure, key distribution channels, and healthcare provider preferences to optimize market entry, partnerships, and product positioning strategies.
      • Healthcare Infrastructure Opportunities : Identify expansion opportunities across Germany's advanced diagnostic sector, including major hospital networks, specialized laboratories, and blood banks seeking innovative phlebotomy solutions.

      Frequently asked questions

      What is the current size of Germany's blood collection devices market?

      Germany's blood collection devices market is valued at $728.1 million in 2025.

      What is the projected market size for Germany by 2030?

      Germany's blood collection devices market is forecast to reach $1,086.3 million by 2030.

      What is the CAGR for Germany's blood collection devices market?

      Germany's blood collection devices market is expected to grow at a compound annual growth rate of 8.3% from 2025 to 2030.

      What factors are driving growth in Germany's blood collection devices market?

      Key growth drivers in Germany include an aging population, rising chronic disease prevalence, stringent safety regulations, healthcare digitalization, and strong adoption of safety-engineered devices.

      Which end-users dominate Germany's blood collection devices market?

      Germany's blood collection devices are primarily used in hospitals, diagnostic laboratories, blood banks, and clinical settings that require safe and efficient phlebotomy solutions.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Secondary Research

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Primary Research

      In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

      The following is a breakdown of the primary respondents:

      Blood Collection Devices Market

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      Blood Collection Devices Market

      Data Triangulation

      The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.

      Stakeholders

      • Healthcare Service Providers (Hospitals and Pathology Centers)
      • Blood Collection Product Manufacturers
      • Blood Banks
      • Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
      • Market Research and Consulting Firms
      • Venture Capitalists and Investors

      Report Objectives

      • To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
      • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
      • To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
      • To profile the key players in the market and comprehensively analyze their market positions and core competencies
      • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market

       

      Get the Full Blood Collection Devices Market Report

      Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status